Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
<i>In vivo</i>, PST 3.1a reduced intersegmental vessel formation and vascularization of the subintestinal plexus in zebrafish embryos and also altered pathologic angiogenesis and glioblastoma progression <i>in vivo</i>.
|
30817178 |
2019 |
Adult Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
<i>In vivo</i>, PST 3.1a reduced intersegmental vessel formation and vascularization of the subintestinal plexus in zebrafish embryos and also altered pathologic angiogenesis and glioblastoma progression <i>in vivo</i>.
|
30817178 |
2019 |
Childhood Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
<i>In vivo</i>, PST 3.1a reduced intersegmental vessel formation and vascularization of the subintestinal plexus in zebrafish embryos and also altered pathologic angiogenesis and glioblastoma progression <i>in vivo</i>.
|
30817178 |
2019 |
Glioblastoma Multiforme
|
0.020 |
Biomarker
|
disease |
BEFREE |
<i>In vivo</i>, PST 3.1a reduced intersegmental vessel formation and vascularization of the subintestinal plexus in zebrafish embryos and also altered pathologic angiogenesis and glioblastoma progression <i>in vivo</i>.
|
30817178 |
2019 |
Carcinoma in situ of uterine cervix
|
0.010 |
Biomarker
|
disease |
BEFREE |
88.2% (60/68) of the histologically confirmed CIN 3 lesions and six out of nine (66.6%) CIN 2 lesions were positive PST+.
|
20129068 |
2009 |
Cervical Squamous Cell Carcinoma In Situ
|
0.010 |
Biomarker
|
disease |
BEFREE |
88.2% (60/68) of the histologically confirmed CIN 3 lesions and six out of nine (66.6%) CIN 2 lesions were positive PST+.
|
20129068 |
2009 |
Cervix Intraepithelial Neoplasia Grade 3 AJCC v7
|
0.010 |
Biomarker
|
disease |
BEFREE |
88.2% (60/68) of the histologically confirmed CIN 3 lesions and six out of nine (66.6%) CIN 2 lesions were positive PST+.
|
20129068 |
2009 |
Cervical intraepithelial neoplasia grade 2
|
0.010 |
Biomarker
|
disease |
BEFREE |
88.2% (60/68) of the histologically confirmed CIN 3 lesions and six out of nine (66.6%) CIN 2 lesions were positive PST+.
|
20129068 |
2009 |
Malignant neoplasm of breast
|
0.400 |
PosttranslationalModification
|
disease |
BEFREE |
Breast cancer tissue showed a higher methylation rate of SULT1A1 than normal and benign tissue at both P1 (p=0.001) and P0 (p=0.006) promoters with statistical significance.
|
16328031 |
2006 |
Breast Carcinoma
|
0.400 |
PosttranslationalModification
|
disease |
BEFREE |
Breast cancer tissue showed a higher methylation rate of SULT1A1 than normal and benign tissue at both P1 (p=0.001) and P0 (p=0.006) promoters with statistical significance.
|
16328031 |
2006 |
Bladder Neoplasm
|
0.070 |
GeneticVariation
|
disease |
LHGDN |
Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study.
|
18365755 |
2008 |
Malignant neoplasm of breast
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.
|
11219777 |
2001 |
Breast Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.
|
11219777 |
2001 |
Malignant neoplasm of breast
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Sulfotransferase 1A1 (SULT1A1) polymorphism and breast cancer risk in Chinese women.
|
15093672 |
2004 |
Breast Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Sulfotransferase 1A1 (SULT1A1) polymorphism and breast cancer risk in Chinese women.
|
15093672 |
2004 |
Malignant neoplasm of breast
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
SULT1A1 genotype did not correlate with any prognostic or predictive markers associated with breast cancer.
|
16317586 |
2006 |
Breast Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
SULT1A1 genotype did not correlate with any prognostic or predictive markers associated with breast cancer.
|
16317586 |
2006 |
Malignant Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
SULT1A1 genotypes were successfully detected using the PCR-RFLP assay in 60 primary brain tumor patients and 156 hospital-based healthy control individuals with no history of cancer or precancerous disorder.
|
17605044 |
2008 |
Primary malignant neoplasm
|
0.100 |
GeneticVariation
|
group |
BEFREE |
SULT1A1 genotypes were successfully detected using the PCR-RFLP assay in 60 primary brain tumor patients and 156 hospital-based healthy control individuals with no history of cancer or precancerous disorder.
|
17605044 |
2008 |
Chronic myeloproliferative disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
SULT1A1*2 showed significant risk association with UADT-MPN (odds ratio (OR)=5.50, 95% confidence interval (CI): 1.09, 27.7).
|
18854828 |
2008 |
Squamous cell carcinoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Sulfotransferase 1A1 haplotypes associated with oral squamous cell carcinoma susceptibility in male Taiwanese.
|
19126640 |
2009 |
Carcinoma of Male Breast
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
SULT1A1 gene deletion was observed in 10 of the 72 MBCs (13.9%).
|
23711090 |
2013 |
Malignant neoplasm of male breast
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
SULT1A1 gene deletion was observed in 10 of the 72 MBCs (13.9%).
|
23711090 |
2013 |
Malignant neoplasm of breast
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
SULT1A1 Arg213His didn't show any association with breast cancer, but the possible risk in Asian population needs further investigation.
|
25225888 |
2014 |
Breast Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
SULT1A1 Arg213His didn't show any association with breast cancer, but the possible risk in Asian population needs further investigation.
|
25225888 |
2014 |